• Title/Summary/Keyword: Biotechnological products

Search Result 43, Processing Time 0.032 seconds

Investigation of International Nonproprietary Names (INN) Nomenclature System For Biotechnological Products (생명공학의약품의 국제일반명 명명체계 조사)

  • Kim, Eun-Sook;Song, Jae-In;Moon, A-Ree
    • Toxicological Research
    • /
    • v.23 no.2
    • /
    • pp.179-187
    • /
    • 2007
  • An International Nonproprietary Name (INN) identifies a pharmaceutical substance or active pharmaceutical ingredient by a unique name that is globally recognized and is of public property. Also known as the generic or common names, the official INNs are provided by national and international nomenclature bodies such as United States Adopted Names (USAN), British Approved Names (BAN), Japanese Accepted Names (JAN) and World Health Organization (WHO). Due to the increasing interest on the development of biotechnological products in Korea, needs for the formulated nomenclature body in Korea are arising for systemic management of newly developed biotechnological products. This study investigated and analyzed nomenclature systems and procedures for the selection of recommended INN for biotechnological products in WHO, USAN and JAN. Based on these documents from advanced countries, we suggested a Korean INN nomenclature organization named KAN (Korean Adopted Names or Korean Agreed Names). Composition and roles of KAN and KAN expert committee and a working process for INN selection/approval were also proposed. Taken together, this study provides a detailed information on INN system recognized worldwide and suggests guidelines for establishment of INN nomenclature system for biotechnological products in Korea.

Determination of Remained Host Derived Proteins in the Commercially Available Biotechnological Products Using a Sandwich Enzyme Linked Immunosorbent Assay Method (Sandwich ELISA 방법을 이용한 생물공학의약품에 잔류하는 숙주유래단백질의 검출법개발)

  • 성혜윤;최규실;김창민;민홍기;용군호
    • Biomolecules & Therapeutics
    • /
    • v.2 no.2
    • /
    • pp.120-125
    • /
    • 1994
  • We obtained the total protein antibodies of Saccharomyces cerevisiae KCTC 1720 and Escherichia coli K-12 from the rabbit and the guinea pig to determine the host-derived proteins which may be remained in biotechnological products. The protein concentration of rabbit antibodies was 4.05 mg/mι in the case of yeast, 7.14 mg/mι in the case of E. coli and that of guinea pig antibodies was 1.90 mg/mι in the case of yeast, 7.17 mg/mι in the case of E. coli, respectively. To determine remained host-derived proteins in biotechnological products which produced by the hosts, S. cerevisiae or E. coli, we used a sandwich enzyme linked immunosorbent assay method in 96 well microplate. When the method applied to determine the remained host-derived proteins in commercial biotechnological products, it detected less than 3.5 ng/vial in human growth hormone, less than 1 ng/vial in hepatitis B vaccine and interferon-${\gamma}$ and 2~23 ng/vial in interferon-$\alpha$. The method can be used to determine the remained host-derived protein in biotechnological products.

  • PDF

Collaborative Study for the Establishment of a National Reference Preparation for Erythropoietin

  • Jin, Jae-Ho;Kim, Gi-Hyun;Shin, Won;Shin, Ji-Soon;Choi, Jong-Yoon;Yoon, Sei-Ung;Kim, Min-Sung;Kim, Yang-Woo;Lee, Seung-Woo
    • Proceedings of the PSK Conference
    • /
    • 2003.04a
    • /
    • pp.253.2-253.2
    • /
    • 2003
  • National regulatory authority have the duty to ensure that available pharmaceutical products are of the required quality. This is particularly difficult for biotechnological products, the quality of which cannot be established entirely by test on the material in the final container. In general biotechnological products are distinguished from other drugs by being derived from genetically modified microorganism to humans, and frequently have a complex molecular structure. (omitted)

  • PDF

Biotechnological Approaches in Sericultural Science and Technology of Uzbekistan

  • Madyarov Shukhrat R.
    • International Journal of Industrial Entomology and Biomaterials
    • /
    • v.11 no.1
    • /
    • pp.13-19
    • /
    • 2005
  • Biotechnological researches in Central Asian Research Institute of Sericulture were developed since 1981 when laboratory of artificial diets for mulberry silk­worm was created. The researches were directed not only to creation of accessible artificial diets (AD) for off-season mass rearing of economical beneficial insect and for industrialization of sericulture but also to obtaining of easy reproducible source of animal proteins, carbohydrates, lipids, enzymes, enzymes inhibitors and other metabolites - bioresource for manufacture of oriental medicine preparations. Space experiments with silkworms became possible with use of AD. These experiments used mulberry silkworm as high effective board test organism with outstanding developmental, reproductive and transgenic properties having impor­tant significance in future of cosmonautics. Introduction to practice of bioprotective and ecologically pure method of drying and sterilizing of green cocoons and by-products of silk manufacture allows to increase efficiency of cocoons reeling technology as well as to preserve nativity of biological active substances in mulberry silkworm pupae that is unachievable by traditional methods of raw material processing. New spheres of application of two important silk proteins - fibroin and sericin in medicine, cosmetics, for bio- and nanotechnology are opening with use of biotechnological approaches. At present the achievements and experience of R & D in these fields are used in creation of modern pests biocontrol agents. Schemes of efficient processing of cocoon raw material, by-products and wastes of sericulture and cocoon processing are devel- Institute of Physiology and Biophysics, Uzbek Academy of Sciences, I, Niyazov street, 700095, Tashkent, Uzbekistan. oped for obtaining of traditional and new consumer products.

Roundup BioKorea -Workshop on Guiding Research Products to Commercial BioProducts-

  • Jung, Youn-Chan
    • Proceedings of the PSK Conference
    • /
    • 2003.10a
    • /
    • pp.25-25
    • /
    • 2003
  • “Roundup BioKorea” is the project to develop the role of Korea Food and Drug Administration in leading the process of the effective materials from basic research work to licensed commercial BioProducts. Korean government has invested a large amount of budget to a biotechnological area by “Biotech 2000” program since 1994. (omitted)

  • PDF

Recent Advances in Biotechnology Applications to Aquaculture

  • Lakra, W.S.;Ayyappan, S.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • v.16 no.3
    • /
    • pp.455-462
    • /
    • 2003
  • Biotechnological research and development are moving at a very fast rate. The subject has assumed greatest importance in recent years in the development of agriculture and human health. The science of biotechnology has endowed us with new tools and tremendous power to create novel genes and genotypes of plants, animals and fish. The application of biotechnology in the fisheries sector is a relatively recent practice. Nevertheless, it is a promising area to enhance fish production. The increased application of biotechnological tools can certainly revolutionise our fish farming besides its role in biodiversity conservation. The paper briefly reports the current progress and thrust areas in the use of synthetic hormones in fish breeding, production of monosex, uniparental and polyploid individuals, molecular biology and transgenesis, biotechnology in aquaculture nutrition and health management, gene banking and the marine natural products.

Re-evaluation of the Genus Antrodia (Polyporales, Basidiomycota) in Korea

  • Park, Myung Soo;Quan, Ying;Jung, Paul Eunil;Oh, Seung-Yoon;Jang, Yeongseon;Kim, Jae-Jin;Lim, Young Woon
    • Mycobiology
    • /
    • v.42 no.2
    • /
    • pp.114-119
    • /
    • 2014
  • The wood decay fungi Antrodia P. Karst. play important ecological roles and have significant industrial and economic impacts as both wood degraders and sources of pharmaceutical and biotechnological products. Although each Antrodia species has distinct morphological characteristics, the misidentification rate is especially high due to their simple morphological characters. A combination of morphological and internal transcribed spacer region sequence analyses revealed that 27 of 89 specimens previously identified by morphology alone were correct, whereas 35 of these specimens were misidentified as other Antrodia species. We report here that seven Antrodia species exist in Korea (A. albida, A. heteromorpha, A. malicola, A. serialis, A. sinuosa, A. sitchensis, and A. xantha) and based on these specimens, we provide taxonomic descriptions of these species, except for A. serialis, which was only confirmed by isolate.